Lilly rises after Viking reports maintenance-dosing weight-loss preservation
Lilly shares rose 0.8% to $1,174.37 Tuesday after Viking Therapeutics reported maintenance-dosing results for VK2735, with patients preserving up to 97% of prior weight loss.